SCHEMBL6323958

SCHEMBL6323958

Cc1ccc(S(=O)(=O)CCCOC(=O)c2ccccc2NC(=O)NS(C)(=O)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
KDM4E B2RXH2 6/20 0.46
HSD17B10 Q99714 3/20 0.46
TSHR P16473 2/20 0.46
KMT2A Q03164 7/20 0.45
ALDH1A1 P00352 6/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
POLB P06746 2/20 0.45
PSMD14 O00487 1/20 0.45
MMP2 P08253 1/20 0.45
DNMT1 P26358 1/20 0.45
RECQL P46063 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HPGD P15428 3/20 0.43
MEN1 O00255 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326148 0.97 LMNA (0.48) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6322910 0.96 LMNA (0.47) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL7601270 0.91 LMNA (0.51) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6326429 0.90 LMNA (0.47) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6324390 0.90 LMNA (0.47) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6400227 0.88 KMT2A (0.47) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6326478 0.88 LMNA (0.50) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6332151 0.87 LMNA (0.49) LMNAKDM4EHSD17B10TSHRKMT2A
SCHEMBL6332315 0.85 LMNA (0.43) LMNAKDM4EKMT2AALDH1A1L3MBTL1
SCHEMBL6324416 0.82 LMNA (0.42) LMNAKDM4EKMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065178-A1 Substituted diazabicycloakane derivatives ABBOTT LABORATORIES 2005-03-24 US disclosed
US-6858565-B2 Thermosensitive recording material and novel color developer compounds OJI PAPER CO., LTD. (JP) 2005-02-22 US disclosed
US-20030040434-A1 Thermosensitive recording material and novel color developer compounds OJI PAPER CO., LTD. (JP) 2003-02-27 US disclosed
EP-1264707-A2 Thermosensitive recording material and novel color developer compounds OJI PAPER CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065178-A1 Substituted diazabicycloakane derivatives CHRNA7, CHRNA1, CHRNA5 LMNA 1975/4885KDM4E 2327/4885HSD17B10 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.